Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans

PLoS Genetics

Volumn 7, Issue 6, 2011, Pages

  Freedman, Barry I ^a   Langefeld, Carl D ^a   Lu, Lingyi ^a   Divers, Jasmin ^a   Comeau, Mary E ^a   Kopp, Jeffrey B ^b   Winkler, Cheryl A ^c   Nelson, George W ^c   Johnson, Randall C ^c,d   Palmer, Nicholette D ^a   Hicks, Pamela J ^a   Bostrom, Meredith A ^a   Cooke, Jessica N ^a   McDonough, Caitrin W ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Bioinformatique et Chimie Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; PROTEIN FRMD3; REGULATOR PROTEIN; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; FRMD3 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; MOLECULAR MOTOR; MYH9 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AFRICAN AMERICAN; ALLELE; APOLIPOPROTEIN L1 GENE; ARTICLE; CHROMOSOME 22; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FRMD3 GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MYOSIN HEAVY CHAIN 9 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; CHRONIC KIDNEY FAILURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AFRICAN AMERICANS; AGED; APOLIPOPROTEINS; CHROMOSOMES, HUMAN, PAIR 22; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 79959826611     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002150     Document Type: Article

References (28)

1. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184.
2. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192.
3. Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, et al. (2009) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75: 736-745.
4. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, et al. (2009) Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 11: 3366-3371.
5. Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, et al. (2009) Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol 29: 626-632.
6. Reeves-Daniel AM, Iskandar SS, Bowden DW, Bostrom MA, Hicks PJ, et al. (2010) Is Collapsing C1q Nephropathy Another MYH9-Associated Kidney Disease? A Case Report. American Journal of Kidney Diseases 55: e21-e24.
7. Pattaro C, Aulchenko YS, Isaacs A, Vitart V, Hayward C, et al. (2009) Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 76: 297-306.
8. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845.
9. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, et al. (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345-350.
10. Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, et al. (2010) The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans. Journal of the American Society of Nephrology 21: 1422-1426.
11. Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, et al. (2010) Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 19: 1805-1815.
12. Gopalakrishnan I, Iskandar SS, Daeihagh P, Divers J, Langefeld CD, et al. (2011) Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol 42: 291-294.
13. Divers J, Freedman BI, (2010) Susceptibility genes in common complex kidney disease. Curr Opin Nephrol Hypertens 19: 79-84.
14. Nunez M, Saran AM, Freedman BI, (2010) Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene. Adv Chronic Kidney Dis 17: 44-51.
15. McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, et al. (2011) A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 79 (5): 563-572.
16. Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet.
17. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58 (6): 1403-1410.
18. Murea M, Freedman BI, (2010) Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens.
19. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 11 (In Press).
20. Maeda S, Araki SI, Babazono T, Toyoda M, Umezono T, et al. (2010) Replication study for the association between 4 loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes.
21. Ramez M, Blot-Chabaud M, Ciuzeaud F, Chanan S, Patterson M, et al. (2003) Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. Kidney Int 63: 1321-1337.
22. Frame MC, Patel H, Serrels B, Lietha D, Eck MJ, (2010) The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol 11: 802-814.
23. Ni X, Ji C, Cao G, Cheng H, Guo L, et al. (2003) Molecular cloning and characterization of the protein 4.10 gene, a novel member of the protein 4.1 family with focal expression in ovary. J Hum Genet 48: 101-106.
24. Hoover KB, Bryant PJ, (2000) The genetics of the protein 4.1 family: organizers of the membrane and cytoskeleton. Curr Opin Cell Biol 12: 229-234.
25. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspai M, et al. (1998) The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23: 281-282.
26. Baines AJ, (2006) A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function. BMC Genomics 20: 85.
27. Tang H, Peng J, Wang P, Risch NJ, (2005) Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 28: 289-301.
28. Piegorsch WW, Weinberg CR, Taylor JA, (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13: 153-162.